GAIN THERAPEUTICS, INC Increase (Decrease) in Obligation, Pension Benefits
GAIN THERAPEUTICS, INC (GANX) reported Increase (Decrease) in Obligation, Pension Benefits of -$57.28 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPensionPlanObligations · last filed 2026-08-11
- GAIN THERAPEUTICS, INC increase (decrease) in obligation, pension benefits for the quarter ending 2026-06-30 was -$30.57K.
- GAIN THERAPEUTICS, INC increase (decrease) in obligation, pension benefits for the quarter ending 2026-03-31 was -$26.71K.
- GAIN THERAPEUTICS, INC increase (decrease) in obligation, pension benefits for the quarter ending 2025-06-30 was -$45.22K.
- GAIN THERAPEUTICS, INC increase (decrease) in obligation, pension benefits for the quarter ending 2025-03-31 was -$23.18K.
- GAIN THERAPEUTICS, INC increase (decrease) in obligation, pension benefits for fiscal 2025 was -$130.57K.
- GAIN THERAPEUTICS, INC increase (decrease) in obligation, pension benefits for fiscal 2024 was -$122.92K, a 2047.01% decline from fiscal 2023.
- GAIN THERAPEUTICS, INC increase (decrease) in obligation, pension benefits for fiscal 2023 was $6.31K.
| Period end | Increase (Decrease) in Obligation, Pension Benefits 3 month | Increase (Decrease) in Obligation, Pension Benefits 6 month | Increase (Decrease) in Obligation, Pension Benefits 12 month |
|---|---|---|---|
| 2026-06-30 | -$30.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$57.28K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | -$26.71K 10-Q · filed 2026-05-11 | ||
| 2025-12-31 | -$130.57K 10-K · filed 2026-03-26 | ||
| 2025-06-30 | -$45.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$68.39K 10-Q · filed 2026-08-11 | |
| 2025-03-31 | -$23.18K 10-Q · filed 2026-05-11 | ||
| 2024-12-31 | -$122.92K 10-K · filed 2026-03-26 | ||
| 2023-12-31 | $6.31K 10-K · filed 2025-03-27 | ||
| 2021-03-31 | $22.91K 10-Q · filed 2021-05-10 | ||
| 2020-03-31 | $8.09K 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |